AMERICAN INTERNATIONAL GROUP, INC. - JOUNCE THERAPEUTICS INC ownership

JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 102 filers reported holding JOUNCE THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 1.0%.

Quarter-by-quarter ownership
AMERICAN INTERNATIONAL GROUP, INC. ownership history of JOUNCE THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$37,623
+70.0%
20,337
+2.0%
0.00%
Q4 2022$22,125
-52.9%
19,932
-0.4%
0.00%
Q3 2022$47,000
-21.7%
20,004
+1.4%
0.00%
Q2 2022$60,000
-45.9%
19,722
+20.5%
0.00%
-100.0%
Q1 2022$111,000
-24.0%
16,367
-6.6%
0.00%0.0%
Q4 2021$146,000
+9.0%
17,519
-2.9%
0.00%0.0%
Q3 2021$134,000
+6.3%
18,043
-2.3%
0.00%
Q2 2021$126,000
+22.3%
18,472
+83.7%
0.00%
Q1 2021$103,000
+47.1%
10,057
+0.3%
0.00%
Q4 2020$70,000
-16.7%
10,030
-2.8%
0.00%
Q3 2020$84,000
+15.1%
10,318
-2.2%
0.00%
Q2 2020$73,000
+62.2%
10,553
+10.2%
0.00%
Q1 2020$45,000
-48.9%
9,578
-5.5%
0.00%
Q4 2019$88,000
+158.8%
10,132
-0.8%
0.00%
Q3 2019$34,000
-33.3%
10,216
-0.7%
0.00%
Q2 2019$51,000
-17.7%
10,288
+2.3%
0.00%
Q1 2019$62,000
+77.1%
10,054
-3.1%
0.00%
Q4 2018$35,000
-48.5%
10,380
-0.8%
0.00%
Q3 2018$68,000
-13.9%
10,460
+1.8%
0.00%
Q2 2018$79,000
-61.8%
10,271
+11.0%
0.00%
-100.0%
Q1 2018$207,000
+66.9%
9,253
-5.1%
0.00%
Q4 2017$124,000
-16.8%
9,752
+2.0%
0.00%
-100.0%
Q3 2017$149,000
+156.9%
9,559
+132.2%
0.00%
Q2 2017$58,0004,1170.00%
Other shareholders
JOUNCE THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
TRV GP II, LLC 9,200,349$64,402,00044.86%
TRV GP III, LLC 3,048,780$21,342,0001.83%
SILVERARC CAPITAL MANAGEMENT, LLC 406,665$2,847,0001.65%
Sofinnova Investments, Inc. 925,280$6,477,0000.39%
Omega Fund Management, LLC 334,965$2,345,0000.35%
Yorktown Management & Research Co Inc 49,200$344,0000.31%
Woodline Partners LP 940,902$6,586,0000.18%
HUSSMAN STRATEGIC ADVISORS, INC. 51,000$357,0000.09%
HORIZON FINANCIAL SERVICES, LLC 12,005$84,0000.08%
Gyon Technologies Capital Management, LP 26,893$188,0000.06%
View complete list of JOUNCE THERAPEUTICS INC shareholders